Skip to main content

Table 1 Patient demographics

From: Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

Characteristics

All Patients

(N = 18) n (%)

Age at SBRT, y (median (range))

65 (31, 88)

Gender (male/female)

11 (61.1)/7 (38.9)

ECOG status

 ECOG ≤ 1

17 (94.4)

 ECOG ≥ 2

1 (5.6)

Primary diagnosis

 Liver

4 (22.2)

 Colorectal

7 (38.9)

 Esophagus

1 (5.6)

 Pancreas

4 (22.2)

 Gallbladder

1 (5.6)

 Lung

1 (5.6)

Imaging for staging

 PET

16 (88.9)

 CT

1 (5.6)

 MRI

1 (5.6)

Number of lines of chemotherapy prior to SBRT

 0

11 (61.1)

 1

2 (11.2)

 2

5 (27.8)

Number of metastasis at time of SBRT

 1

8 (44.4)

 2

6 (33.3)

 3

1 (5.6)

 4

3 (16.7)

SBRT treatment site

 Thorax

7 (38.9)

 Abdomen

8 (44.4)

 Pelvis

3 (16.7)